Shares slip after a run-up that followed December disclosure of Pershing Square chief’s plan to end government ...
The Food and Drug Administration is facing some backlash from hedge fund manager Bill Ackman about how long it took to ban ...
The scene is set for a skirmish between thirsty tycoons and wary investors in would-be targets. Jacobs’ bidding vehicle, QXO, is an artefact of financial engineering. He bought a tiny, listed ...
Oxman was a rock star researcher at MIT. Now she wants to build the wildest innovation lab of the 21st century. Four hundred ...